Objectives: The aim of this study was to quantitatively assess changes in collagen structure using MR T1-and T2*-mapping in a novel controlled ex vivo tendon model setup. Materials and Methods: Twenty-four cadaveric bovine flexor tendons underwent MRI at 3 T before and after chemical modifications, representing mechanical degeneration and augmentation. Collagen degradation (COL), augmenting collagen fiber cross-linking (CXL), and a control (phosphate-buffered saline [PBS]) were examined in experimental groups, using histopathology as standard of reference. Variable echo-time and variable-flip angle gradient-echo sequences were used for T2*-and T1-mapping, respectively. Standard T1-and T2-weighted spin-echo sequences were acquired for visual assessment of tendon texture. Tendons were assessed subsequently for their biomechanical properties and compared with quantitative MRI analysis. Results: T1-and T2*-mapping was feasible and repeatable for untreated (mean, 545 milliseconds, 2.0 milliseconds) and treated tendons. Mean T1 and T2* values of COL, CXL, and PBS tendons were 1459, 934, and 1017 milliseconds, and 5.5, 3.6, and 2.5 milliseconds, respectively. T2* values were significantly different between enzymatically degraded tendons, cross-linked tendons, and controls, and were significantly correlated with mechanical tendon properties (r = −0.74, P < 0.01). T1 values and visual assessment could not differentiate CXL from PBS tendons. Photo-spectroscopy showed increased autofluorescence of crosslinked tendons, whereas histopathology verified degenerative lesions of enzymatically degraded tendons. Conclusions: T2*-mapping has the potential to detect and quantify subtle changes in tendon collagen structure not visible on conventional clinical MRI. Tendon T2* values might serve as a biomarker for biochemical alterations associated with tendon pathology.
T he Achilles tendon and its enthesis (attachment at the bone) enable the mechanical force transmission from the calf muscles to the heel and are therefore important biomechanical structures for plantar flexion of the foot. The major component of tendon dry weight is collagen type I (65%-87%), embedded in a noncollagen extracellular matrix that mainly consists of water and small leucine-rich proteoglycans with glycosaminoglycan (GAG) side chains. 1, 2 This extracellular matrix undergoes increasing disorganization with advancing stages of tendon disease, with concomitant loss of mechanical integrity [3] [4] [5] [6] and change in water permeability. Magnetic resonance imaging (MRI) is commonly used for assessing tendon disease based on qualitative morphologic criteria, but interrater reliability varies substantially ranging from moderate to excellent. [7] [8] [9] Moreover, sensitivity of standard turbo spin-echo T1-and T2-weighted sequences for early tendon degeneration is limited by the short T2 MR characteristics by highly organized tendon tissue components. Because tendons have a characteristically short T2 signal, use of standard MR sequences results in poorly visualized tendon structures in both healthy and slightly degenerated Achilles tendon. 10 With ultrashort echo-times pulse sequences, it is possible to gain signal from tissues characterized by a short T2 time (such as tendons) before complete signal decay. 11, 12 Alternatively, manipulated variable echo-time sequences have been shown to be useful for visualization and quantitative assessment of fast-relaxing tissues, providing high image quality at 3 T and T2*-mapping with very-short echo-times below 1 millisecond. [13] [14] [15] [16] The short T2* component of the tendon is thought to represent water protons bound to macromolecules such as GAGs, whereas the long T2* component is associated with the free water content of the tendon. 17 During tendon cross-linking, which is associated with tendon aging and early tendon degeneration, 11 changes in tendon structure lead to a shift from free to macromolecule bound water molecules, whereas proceeding tendon degeneration leads to collagen disruption and an increase of the free water content. The relation of bound versus free water protons associated with different tendon collagen structures 18 might be detected and quantified by T2*-mapping of short echo-times 17 and might therefore serve as a biomarker for collagen degradation. 19 Detection of changes within pathological tendons in the absence of early morphological changes on standard imaging could plausibly provide clinical benefit, for instance, in the prescription of prophylactic physiotherapy to mitigate disease progression before the onset of deeper structural damage. 20 The aim of the present study was to implement a phantom model for quantitative assessment of changes in tendon structure and mechanical function. Ultimately our goal was to quantitatively assess the potential for reliably detecting changes in the physical collagen matrix of tendon tissue using T1-and T2*-mapping. We tested this using healthy, enzymatically degraded and augmented bovine flexor tendons, placing the MR measurements in context of histological and mechanical changes induced by the tissue alteration.
MATERIALS AND METHODS

Study Design
Three experimental groups, each with 8 tendons, were investigated by MRI. The experiment was performed at 2 different time-points (Fig. 1) .
Half of all tendons were assessed by destructive biomechanical testing, and the other half were processed for histological analysis.
To obtain a reproducible model with variable mechanical properties of a tendon, which reflect degenerative changes in the diseased collagen matrix, we targeted the mechanical properties of the tendon with biochemical substances. It is well known that collagen cross-linking agents affect the tendon's elastic (ie, elastic modulus) and viscoelastic (ie, stressrelaxation) behavior, 3, 21 and elevated tissue cross-linking has been increasingly associated with tendon scarring, diabetic tendinopathy, and inflammatory connective tissue disease. 22 A denser collagen interconnection, induced by cross-linking, also results in a decreased matrix porosity, which consequently will result in reduced water movement. Correspondingly collagenase treatment tends to increase porosity and results in less constrained tissue water movement. Collagenase also affects the tendon's elastic behavior 23 and leads to a degenerated tendon tissue in a concentration-and timedependent fashion by disrupting their collagen continuity.
After an initial image acquisition of yet untreated specimens, 0.2 mL of different solutions were injected with a 24-gauge cannula or gauge needle directly in the middle portion of the respective tendon. In the control group, phosphate-buffered saline (PBS) was injected. For the 2 interventional groups, either collagenase B (COL; 0.226 U/mg lyo; PBS with Ca2+) with a concentration of 12 mg/mL or a collagen cross-linking (CXL) solution (2 mL, 80 mM genipin in PBS and 2% DMSO) with a concentration of 80 mM was infiltrated.
After a second scanning run, the MRI clamping device was then stored at 37°C in an incubator after wrapping all tendons in salinesoaked gauzes and sealing them tightly to prevent dehydration. After 24 hours, tendons were then scanned again.
Immediately after the final scan, tendons were removed from the clamping device and either analyzed biomechanically or histologically to assess the effects of the imposed chemical treatment.
Phantoms
For this study, 12 bovine flexor tendons with an average crosssectional area of 20 mm 2 were obtained freshly from a local abattoir (Metzgerei Angst, Zurich, Switzerland). Immediately after purchase, the tendons were prepared by removing synovial lining and unnecessary soft tissue. Tendons were cut in half (8 cm) and randomly assigned into 3 groups while they were covered in saline-soaked gauze to avoid sample dehydration. To ensure a reproducible testing environment, tendon specimens were mounted on a 3-dimensional printed custom-made MRI compatible clamping device, placed in a plastic container and filled with PBS. The container was then sealed airtight with its lid and positioned horizontally into the detector reel, so that tendons were oriented perpendicular to the axis of the main magnetic field (Fig. 2) .
Magnetic Resonance Imaging
Magnetic resonance imaging was performed on a 3 T MRI system (MAGNETOM Skyra; Siemens Healthcare, Erlangen, Germany) using a dedicated knee coil. The MRI study protocol consisted of the standard clinical MRI protocol at our department for the examination of the Achilles tendon as well as T1-and T2*-mapping sequences, which were optimized for imaging of tissues exhibiting short T2* values. A variable flip-angle gradient-echo sequence using short radiofrequency excitation pulses and short echo-times was used for T1-mapping. For T2*-mapping, a variable echo-time sequence 13, 14 consisting of a series of 4 multiecho gradient-echo acquisitions each collecting 5 echo images. For the complete multiecho acquisition, the first echo time was variable 14 and the 5 echo-train was sequentially shifted to obtain a series of 20 gradient echo images with an echo spacing of 1 millisecond. The imaging protocol and corresponding imaging parameters are displayed in Table 1 .
MRI Data Analysis
T1 values were calculated by the software of the MR system by pixel-wise fitting of the signal intensities obtained at different flip angles to the signal equation of a spoiled gradient echo sequence. T2*-map calculation was performed in Matlab (The MathWorks Inc, Natick, MA), assuming a monoexponential decay of the measured signal intensity S(TE).
T1 and T2* isotropic maps were reformatted in the transverse plane with a slice thickness of 10-mm centered on the injection site at the middle of the tendons (Fig. 3) . Two independent readers (one Although biomechanical properties were investigated during experiment I, test-retest reliability of the setup, histophatology, and fluorescence spectroscopy were performed in experiment II. MRI scan t0 is the initial scan and t24 the scan after 1 day of incubation of samples. To asses reproducibility of the scans using this setup, experiments I and II were performed between 4 weeks' time difference. musculoskeletal radiologist with 6 years of experience, one MRI physicist with 10 years of experience) evaluated the images. Image analysis was fully blinded with respect to specimen grouping, as was analysis of biomechanical test results, and histopathological grading. Imaging datasets were evaluated using T1-mapping and T2*-mapping images with designated ROI implemented freehand along the transverse plane of each tendon and spanning the maximum tendon diameter but avoiding the interface between tendon and surrounding water.
T1 and T2* times were assessed separately for untreated and treated tendons and corresponding percentage differences (Δ) of T1 and T2* times were calculated between matched treated and untreated tendons according to the following algorithm: Δ T1/T2* = (treated − untreated)/untreated Â 100 (%).
As T1 and T2* values and scaling differ in absolute numbers, percentage difference were calculated to better compare relative difference each treatment induced compared with the untreated tendons.
Qualitative Analysis of MRI Data
Two musculoskeletal radiologists (each 6 years of experience), who were blinded to the test condition and all other results, performed standard qualitative clinical analysis. Quality of the bovine tendon was visually assessed before and after treatment using standard T1-weighted and STIR (short tau inversion recovery) images in the coronal plane according to the clinically implemented protocol of the institution.
In this musculoskeletal imaging center, STIR images are implemented in clinical routine for T2-weighted fat suppression to achieve more homogeneous fat suppression.
All images were interpreted on a standard workstation using an integrated picture archiving and communication system (IMPAX 6, Agfa HealthCare, Bonn, Germany).
Quality of the bovine tendon was rated on a 4-point scale with the following specifications: 0, "normal tendon," no T1-/STIR signal alterations; I, "edema," hyperintense areas on T1-weighted images; II, "partial tear," hyperintense on STIR-weighted images; and III, "complete tear," discontinuity of the tendon.
Biomechanical Testing of Tendons
For experiment I, all 12 tendons were tested before and after incubation in a calibrated and certified uniaxial universal material testing machine (Zwick 1456; Zwick GmbH, Ulm, Germany). After applying a preload of 10 N, tendons were stretched to a strain of 5% and the exerted FIGURE 2. Experimental setup: custom-made clamping device with 12 tendon samples rigidly mounted in a plastic box (6 up, 6 down), filled with PBS solution during scans. Collagenase (COL), a cross-linking agent (CXL), or phosphate-buffered saline (PBS) was injected in the tendons to obtain 2 groups undergoing a chemical change in tendon structure and one serving as a control group (PBS). force was recorded. Measurement of tendon stress at small strain levels (≤5% strain) allows to obtain mechanical data of differently treated tendons while keeping the microstructure of the tendon intact. For stress calculation, the cross-sectional area of the tendon specimen was scanned in triplicate using a custom made linear laser measurement device (accuracy, −3.52% ± 1.89%; precision, 0.83%).
24,25
Histopathology and Immunohistology of Tendons
In experiment II, tendons used for histopathology analysis were cut in 3 pieces. The distal and medial (middle) portions were then stored in CryoTubes and filled with formaldehyde solution 4%, ph 7, buffered (Roti-Histofix, Carl Roth GmbH, Germany).
After fixation, the tendons were cut into a longitudinal and 2 cross-sections before they were routinely embedded into paraffin. Cut sections of 2-to 3-μm thickness were afterward sectioned and stained with hematoxylin and eosin. Unstained paraffin-embedded tendon sections were deparaffinized and the antigen demasked by boiling the slides in a pressure cooker (Pascal, DakoCytomation) at 80°C in a basic buffer. Afterward, the tendons were incubated for 1 hour at 37°C with the polyclonal rabbit anti-collagen I antibody (Abcam Ab34710) at a dilution of 1:100. As secondary antibody, the Red Map Kit (760-4154 Roche [rabbit/mouse]) was used and then the slides evaluated by light microscopy.
Collagen cross-linking was verified by making use of its distinct optical spectral properties. Genipin cross-links emit fluorescence at a peak wavelength of 630 nm when excited at 590 nm. 26, 27 Microscopy imaging was performed using an inverted spinning disc confocal microscope (iMic; FEI Munich GmbH, Hillsboro, OR) with a 4x N.A. 0.16 objective (Olympus UPlanSApo) and a Hamamatsu Orca-flash 4.0 Digital CMOS camera (C11440-22CU). A collagen exciting wavelength of 405 nm 22 and a genipin-specific wavelength of 560 nm were used for visualization. Histological tendon sections of the control (PBS) as well as CXL treatment group were mounted on a microscope slice and the unstained slides imaged at one z-plane. Image analysis was done in ImageJ (NIH Image). The ratio of mean pixel intensity between both excitation wavelengths was subsequently compared between PBS and CXL sections using Student t test (n = 6).
Statistical Analysis of T1 and T2* Maps
The data were descriptively reviewed and statistically tested for normality with the Kolmogorov-Smirnov test. All results were expressed as means ± standard deviations. For quantitative analysis, Student t test for not related samples was used to test for significant differences between different groups of tendon preparation. Fisher exact test was used for qualitative visual data analysis, whereas Mann-Whitney U test was used to evaluate significant differences of tendon quality. P values less than 0.05 were considered statistically significant. All statistical analyses were performed using commercially available software (SPSS, release 20.0, Chicago, IL).
RESULTS
Quantitative Analysis and Percentage Difference in Signal (Pre vs Post)
There was a significant difference of T1 and T2* times between untreated and treated tendons in total (both, P < 0.001) and for each group of treatment (COL/CXL/PBS) separately (all, P < 0.04, data not shown). Overall, there was an increase in T1 and T2* relaxation times for each group after incubation, whereas the COL group (porosity increasing) showed almost 200% increase of percentage difference (ΔT1 median, 188%; ΔT2* median, 195%).
However, ΔT1 and ΔT2* showed only significant differences between collagenase-treated tendons and both cross-linked and control tendons but not between cross-linked and control tendons (P > 0.9, P = 0.051; Fig. 4) . 
After Treatment
For T1-mapping (T1_treated), there was a significant difference between COL-treated tendons (median, 1384 milliseconds) showing almost one third higher T1-relaxation times and both CXL-treated (median, 890 milliseconds) and control tendons (PBS; median, 942 milliseconds; all, P < 0.01), whereas no significant difference was seen between CXL and PBS-treated tendons (T1 post, P > 0.3). T2* mapping (T2*_treated) revealed significant differences between COL (median, 5.35 milliseconds) and both CXL (median, 3.44 milliseconds) and PBS (median, 2.10; both, P < 0.01), as well as between CXL and PBS groups (Fig. 5 ).
Reproducibility and Repeatability of the Setup
No significant differences of T1 and T2* times were seen between scans of experiment I and experiment II of untreated tendons (both, P > 0.45; Fig. 6 ). For treated tendons, no significant differences of T1 and T2* times were seen between repetitive T1 and T2* scans of experiment II (both, P > 0.5).
Results Biomechanics
Before incubation, there was no significant correlation between tendon stress at 5% strain and T2* relaxation time (P = 0.22) with an overall mean value of 13.14 ± 5.6 MPa at 5% strain. However, after treatment of tendons, a significant linear regression emerged (r = −0.74, P < 0.01), indicating that treatment agents effected tendon mechanics respective their collagen structure (Fig. 7) . Both treatment groups COL and CXL showed a decrease in stress (−49%, −14%) at 5% strain, compared with the control group (PBS). Mean stress values for COL-, CXL-, and PBS-treated tendons at 5% strain were 5.0 ± 2.3, 8.5 ± 3.0, and 10.1 ± 3.0 MPa, respectively. For T1-mapping, no significant correlation was seen (data not shown).
Qualitative Analysis by Qualitative, Standard Clinical Analysis of MRI
Both readers clearly identified all COL-treated samples as showing visually detectable degenerative changes (grade II 8/8). In the CXL group, no degenerative changes were noted for both readers, but one tendon demonstrated a visible edema associated with the bolus injection for reader 1 (grade 0, 7/8; grade I, 1/8), whereas reader 2 detected 2 CXL-treated tendons with increased signal on STIR imaging (grade 0, 6/8; grade I, 2/8). Similarly, in the PBS group, no degenerative changes were detected, but 2 tendons were identified with visibly increased water content by reader 1 (grade 0, 6/8; grade I, 2/8), whereas 3 tendons were identified by reader 2 (grade 0, 5/8; grade I, 3/8). Thus, no significant differences in visual evaluation of the CXL and PBS groups were detectable by standard evaluation of the MRI scans for both readers (both, P < 0.001).
Results Histopathology and Immunohistology
Visual inspection of CXL-treated tendon samples before histology showed a bluish change in color, whereas COL-treated samples seemed to look more aqueous.
In the tendons treated by collagenase, hematoxylin and eosin staining indicated revealed rounding of cell nuclei, ruptured collagen FIGURE 5. T1 and T2* relaxation times of treated groups: collagenase (COL), collagen cross-linked (CXL), and control (PBS). Boxplots with median and whiskers from minimum to maximum, level of significance is defined as follows: *P < 0.05. FIGURE 6. Reproducibility of the measurement setup between 4 weeks of experiment 1 and 2 (T1, T2* relaxation times of each 12 tendon specimen before treatment). Boxplots with median and whiskers from minimum to maximum, level of significance is defined as follows: *P < 0.05.
fibers, and loss of staining intensity (Fig. 8) . Collagen I immunohistology also showed less intense staining in the degenerating regions of the collagenase-treated tendons. In contrast, cross-linked tendons showed no observable histological abnormalities or regional variations in collagen staining.
Successful collagen cross-linking by the injected genipin solution was indicated by a measured significant differences in tissue autofluorescence at genipin-specific excitations (Fig. 9 ).
DISCUSSION
In this study, we implemented a reproducible tissue-based MRI phantom model to test the potential of T1-and T2*-mapping for quantification of biophysical differences in tendon structure and function induced by a range of chemical treatments. 3, [28] [29] [30] [31] Treated tendons were referenced against benchtop measures of tissue biomechanics and tissue histology. Our results indicated that T1-mapping and T2*-mapping were both capable of detecting collagenase-induced tendon degeneration that resembled advanced stage tendinopathy collagen distortion. Subtle changes with increased tendon cross-linking, however, could be successfully detected using T2*-mapping with short echo times. Interestingly, biomechanical testing correlated exclusively and negatively with T2*-mapping as T2* times and extracellular water content decrease when tendon stress exertion increases.
Conventional MRI shows a limited diagnostic capability for chronic tendinopathy due to intermediate to long echo-times (20-60 milliseconds) of standard spin and gradient echo sequences, which are substantially longer than the intrinsic T2 and T2* values of tendons, which are in the order of a few milliseconds. 32 For this specific application, recently introduced ultrashort echo-times imaging, however, was shown to overcome the limitations of standard sequences allowing visualization and quantification of pathological changes in the human Achilles tendon. 33 For T2*-mapping, a 2-component model reflective of short and long echo-times was proposed. The short component of T2* decay, which is related to bound water of collagen, GAG, and other proteins, allows best for discrimination of healthy from diseased tendons, suggesting that it reflects the changes in water content and collagen orientation more accurately than the long component of T2* decay or T1-mapping, which are related to free water of the interstitial space. 34 Several studies have been performed assessing relaxation times of healthy and degenerated tendons in vivo and in vitro using T2* with short echo-times. 9, 13, 33, [35] [36] [37] [38] [39] [40] Our results in healthy bovine tendons are comparable to T1 and T2* values of a recent ex vivo 34 and in vivo studies, 33, 36 with T2* values ranging from 0.92 to 2.72 milliseconds and T1 values ranging from 311 to 733 milliseconds.
There are many factors that can affect T1 and T2/T2* measurements. Although saline solution is recommended to prevent specimen dehydration 36 and to minimize susceptibility effects, a study by Zheng and Xia 35 reports that saline and PBS solution have different effects on outcome of T2/T2* values. Moreover, T2/T2* times of water nuclei of tendon tissue is dependent on temperature and the orientation of the tissue relative to the static magnetic field B0. [41] [42] [43] [44] Assuming sufficient signal-to-noise ratio, the orientation of the tendons with respect to the main magnetic field does not influence the T1 maps. However, the effective transversal relaxation time T2* depends on the spatial orientation of the tendons with respect to the main magnetic field due to dipolar interactions. Accordingly, we kept temperature and orientation (fiber alignment) of tendons constant (perpendicular to B0) and only immersed tendons in PBS during scanning of samples.
Spatial resolution was adapted to the size of the tendons used in our study and the size of the clamping device. Depending on available signal-to-noise ratio and measurement time, higher spatial resolutions are possible, which could be useful in assessment of smaller tendons.
The influence of magic-angle effects requires further investigation, as do effects associated with imaging tendons of larger and smaller diameter.
In our study, we aimed to evaluate the effect of change in collagen structure on relaxation times in a controlled phantom setting. We chose to investigate alterations to the tendon core collagen structures that are likely to be most reliably discernable by MRI (as opposed to thin structures such as the peritenon). 18 Tendon aging, which refers to the "first" step of tendon degeneration, is characterized by an increase of intercollagen cross-links, as well as increased presence of proteoglycans and other macromolecules. 3 Accordingly, in this "early" stage of tendon degeneration, collagen orientation and water content changes, whereas the tendon structure remains intact. In later stages of tendon degeneration, microtears and degradation can result in collagen distortion with areas of mucoid or fatty degeneration in tendon tissue. 3 Genipin is a chemical agent, which was shown to induce collagen cross-linking in previous in vitro studies, 3, 25, 45 serving as a general model of collagen cross-linking and biophysical effects associated with decreased porosity and decreased mobility of water within the tissue. The effect of tendon treatment with genipin was visible by a slight blueish coloring of the tendons and confirmed by confocal microscopy serving as the reference standard for increased cross-linking. In comparison, severe tendon degeneration as induced by collagenase showed collagen degradation with increased tissue porosity as assessed using histopathological and biomechanical analysis, respectively. Although the simplified models of degeneration and cross-linking are both nonphysiological, they mimic biophysical changes in tissue structure and function that are hallmarks of disease. Further, they are reproducible, and thus well suited for pilot testing of new radiological test phantoms and methods. 3, 23, 25, 45, 46 When comparing healthy and severely degenerated tendons, several in vivo studies have reported a significant increase in T2 and T2* in degenerative tendon tissue. [47] [48] [49] This is consistent with our results showing a significant increase of both T1 (+188%) and T2* (+195%) values in higher degree of tendon degeneration with chemically (collagenase) induced collagen distortion. When comparing healthy and tendons with increased cross-linking, our results showed significantly longer T2* times (+86%) of those functionally modified tendons, whereas T1-mapping and visual analysis failed to distinguish both groups. A noticeable small range of T1 values was observed for the CXL-treated tendons. We hypothesize, as T1 is assumed to reflect (only) the extracellular fluid, which decreases after treatment by CXL, that T1 values decrease compared with the control group and consequently are narrower in range. However, differences were not significant to the control group, which indicated increased presence of extracellular fluid.
The present quantitative and highly controlled work tend to support previous in vivo studies, such as those showing that T2* relaxation times in healthy runners are significantly longer when compared with a normal population (mean percentage increase, 15.7% ± 4.9%), 33 which might be as well explained by an adaption of the tendon matrix (crosslinking) and consecutive changes in the free and/or bound water fractions without patients being symptomatic.
Biomechanical testing correlated exclusively and negatively with T2*-mapping. Accordingly, T2* times increase when tendon stress decreases, which might reflect the increase of extracellular water fraction from cross-linked tendons to collagenase-treated tendons.
Several limitations need to be acknowledged. First, tendons and ligament properties are highly complex, and effects that lead to pathological changes are manifold. 50 In this study, we investigated distinct biophysical changes to the collagen matrix in a controlled phantom and attempted to correlate MRI metrics to histopathological and biomechanical metrics. Although chemical treatments used in this study are both nonphysiological, they are among the best-established means of altering mechanical properties and useful for locally altering tissue function of a phantom in a controlled and reproducible manner. 3, 23, 25, 45, 46 Moreover, we did only perform T1-and T2*-mapping using a 3 T system. However, in this pilot study, we aimed to establish a phantom model of collagen degradation allowing for standardized ex vivo evaluation of tendon biomechanics and MRI properties. Finally, the experimental setup was reproducible between scans (experiments I and II) of untreated tendons and test-retest reliability (experiment II), proving a standardized workflow and reliable setup. However, to improve workflow and optimize a standardized treatment, tendon incubation in a water bath should be considered, to equally effect tendons, which might be more consistent compared with the needle injection applied in this study. Investigation of larger diameter tendons like the human Achilles (60 mm 2 at its smallest cross section, 120 mm 2 at its largest) 51 should be considered for future experiments. However, the authors assume that if biophysical properties are detectable in smaller tendons, they should be even more likely to be reliably quantified in larger diameter tendons.
CONCLUSIONS
A tendon model within a novel, highly controlled setup was successfully introduced in MRI testing environment. Optimized T2*-mapping was inversely and significantly correlated to mechanical function in a range of in vitro experiments on tendons treated by compounds that affect their structure and function. T2* may offer increased potential to detect and quantify early functional changes in collagen structure as it is present in early tendon degeneration before they are visible in standard T1 MRI scans.
